Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy.
Kato T, Okada R, Goto Y, Furusawa A, Inagaki F, Wakiyama H, Furumoto H, Daar D, Turkbey B, Choyke PL, Takakura H, Inanami O, Ogawa M, Kobayashi H. Kato T, et al. Among authors: furumoto h. ACS Pharmacol Transl Sci. 2021 Sep 17;4(5):1689-1701. doi: 10.1021/acsptsci.1c00184. eCollection 2021 Oct 8. ACS Pharmacol Transl Sci. 2021. PMID: 34661083 Free PMC article.
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
Okada R, Kato T, Furusawa A, Inagaki F, Wakiyama H, Fujimura D, Okuyama S, Furumoto H, Fukushima H, Choyke PL, Kobayashi H. Okada R, et al. Among authors: furumoto h. Cancer Immunol Immunother. 2022 Aug;71(8):1877-1887. doi: 10.1007/s00262-021-03124-x. Epub 2022 Jan 11. Cancer Immunol Immunother. 2022. PMID: 35013765 Free PMC article.
Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
Wakiyama H, Furusawa A, Okada R, Inagaki F, Kato T, Furumoto H, Fukushima H, Okuyama S, Choyke PL, Kobayashi H. Wakiyama H, et al. Among authors: furumoto h. Cancer Immunol Immunother. 2022 Dec;71(12):2869-2879. doi: 10.1007/s00262-022-03205-5. Epub 2022 Apr 21. Cancer Immunol Immunother. 2022. PMID: 35445836 Free PMC article.
Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
Furumoto H, Okada R, Kato T, Wakiyama H, Inagaki F, Fukushima H, Okuyama S, Furusawa A, Choyke PL, Kobayashi H. Furumoto H, et al. Cancers (Basel). 2022 Aug 22;14(16):4042. doi: 10.3390/cancers14164042. Cancers (Basel). 2022. PMID: 36011036 Free PMC article.
140 results